publication date: Dec. 20, 2010

In this issue: 

Cancer groups endorse Richard Pazdur for head of FDA’s new Office of Oncology Drug Products. Five candidates are in the running for the job, sources said.

Crawford testimony in 2002 promised job to Pazdur.

Two NCI officials leave for industry, academia: Carl Barrett goes to Novartis, Karen Antman named provost and dean at Boston University.

Download (PDF 311KB)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.